This study highlights the role of retinoid X receptor (RXR) activation in reversing age-related deficits in myelin debris clearance and remyelination. RXR activation enhances the efficiency of microglia and macrophages in clearing debris, facilitating effective remyelination.
The results suggest RXR agonists as potential therapeutic agents for treating age-related CNS disorders like multiple sclerosis, where impaired debris clearance hinders recovery.
This research provides a mechanistic basis for developing RXR-based therapies to overcome barriers to neural repair in aging populations.
